Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer ; volume:10 ; number:1 ; day:29 ; month:1 ; year:2024 ; pages:1-15 ; date:12.2024
Cell death discovery ; 10, Heft 1 (29.1.2024), 1-15, 12.2024
- Creator
-
Larsson, Peter
Pettersson, Daniella
Olsson, Maxim
Sarathchandra, Sithumini
Abramsson, Alexandra
Zetterberg, Henrik
Ittner, Ella
Forssell-Aronsson, Eva
Kovács, Anikó
Karlsson, Per
Helou, Khalil
Parris, Toshima Z.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41420-024-01819-5
- URN
-
urn:nbn:de:101:1-2024040911581801094445
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Larsson, Peter
- Pettersson, Daniella
- Olsson, Maxim
- Sarathchandra, Sithumini
- Abramsson, Alexandra
- Zetterberg, Henrik
- Ittner, Ella
- Forssell-Aronsson, Eva
- Kovács, Anikó
- Karlsson, Per
- Helou, Khalil
- Parris, Toshima Z.
- SpringerLink (Online service)
Other Objects (12)
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Blood-based molecular biomarkers for Alzheimer’s disease
Repurposing mebendazole against triple-negative breast cancer CNS metastasis
Neurofilaments in progressive multiple sclerosis: a systematic review
Detection of subarachnoid haemorrhage with spectrophotometry of cerebrospinal fluid – a comparison of two methods
Amyloid-beta 42 adsorption following serial tube transfer
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Blood-based molecular biomarkers for Alzheimer’s disease
Repurposing mebendazole against triple-negative breast cancer CNS metastasis
Neurofilaments in progressive multiple sclerosis: a systematic review
Detection of subarachnoid haemorrhage with spectrophotometry of cerebrospinal fluid – a comparison of two methods
Amyloid-beta 42 adsorption following serial tube transfer
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Blood-based molecular biomarkers for Alzheimer’s disease
Repurposing mebendazole against triple-negative breast cancer CNS metastasis
Neurofilaments in progressive multiple sclerosis: a systematic review
Detection of subarachnoid haemorrhage with spectrophotometry of cerebrospinal fluid – a comparison of two methods
Amyloid-beta 42 adsorption following serial tube transfer
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions